The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 743K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

38 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Preparation of biotinylated allosamidins with strong chitinase inhibitory activities.EBI
University of Tokyo
Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells.EBI
University of Tokyo
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.EBI
University of Tokyo
Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.EBI
University of Tokyo
Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.EBI
University of Tokyo
Reduced folate derivatives are endogenous substrates for cMOAT in rats.EBI
University of Tokyo
Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.EBI
University of Tokyo
SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail.EBI
University of Tokyo
Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands.EBI
University of Tokyo
Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton.EBI
University of Tokyo
Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs.EBI
University of Tokyo
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists.EBI
University of Tokyo
Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors.EBI
University of Tokyo
Synthesis of biotinylated photoaffinity probes based on arylsulfonamide gamma-secretase inhibitors.EBI
University of Tokyo
Novel gamma-secretase inhibitors discovered by library screening of in-house synthetic natural product intermediates.EBI
University of Tokyo
Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists.EBI
University of Tokyo
Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.EBI
University of Tokyo
Parallel synthesis of DAPT derivatives and their gamma-secretase-inhibitory activity.EBI
University of Tokyo
Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity.EBI
University of Tokyo
Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams.EBI
University of Tokyo
Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.EBI
University of Tokyo
Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.EBI
University of Tokyo
Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.EBI
University of Tokyo
Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.EBI
University of Tokyo
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.EBI
University of Tokyo
Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.EBI
University of Tokyo
Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.EBI
University of Tokyo
The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.EBI
University of Tokyo
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.EBI
University of Tokyo
Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2).EBI
University of Tokyo
Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.EBI
University of Tokyo
Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.EBI
University of Tokyo
Characterization of uremic toxin transport by organic anion transporters in the kidney.EBI
University of Tokyo
Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.EBI
University of Tokyo
Therapeutic compounds and uses thereofBDB
Genentech
Bridged bicyclic kallikrein inhibitorsBDB
Global Blood Therapeutics
 
Molecular Origins of the Slow Streptavidin-Biotin Dissociation KineticsBDB
University of Washington